削弱ANTXR1通过关闭PI3K/AKT通路来抑制质瘤的生长
Chaoyang Zhou, Aijun Liang, Jianzhong Zhang
1Department of Neurosurgery, Jiangxi Provincial People's Hospital the First Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi Province, China.
这项研究表明,ANTXR1通过激活PI3K/AKT通路来促进质瘤生长和存活. 向ANTXR1为脑瘤提供了一个潜在的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 结质瘤,主要的大脑瘤,经常复发,预后不好.
- 了解驱动质瘤的分子机制对于开发有效的治疗方法至关重要.
研究的目的:
- 调查ANTXR1在质瘤发展中的作用.
- 为了阐明在质瘤中ANTXR1的下游调节途径.
主要方法:
- 免疫组织化学评估临床质瘤样本中的ANTXR1表达.
- 在质瘤细胞系中静止或过度表达ANTXR1的lentiviral转染.
- qRT-PCR,西式涂抹,细胞表型测定,以及"体内"异种移植模型.
- 对PI3K/AKT通路的药理操作,以确认ANTXR1的调节作用.
主要成果:
- 与正常大脑相比,ANTXR1在质瘤组织中过度表达.
- 沉默ANTXR1抑制了质瘤细胞的生长,迁移和细胞周期进展,同时促进了细胞亡.
- 过度表达ANTXR1增强了质瘤细胞的增殖和存活率.
- ANTXR1通过PI3K/AKT信号通路调节质瘤的进展.
结论:
- 通过PI3K/AKT通路促进细胞生长,ANTXR1在质瘤瘤发生中发挥着关键作用.
- ANTXR1代表了新型质瘤治疗的有前途的分子标.
更多相关视频
10:13Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
Published on: August 12, 2014
09:43Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation
Published on: January 14, 2014
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The JAK-STAT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
